Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAIL for Health is a Brazilian company dedicated to accelerating impactful initiatives in life sciences by connecting academia, industry, government agencies, and investors. It specializes in designing strategic plans that clarify timelines/investments needed across phases of clinical development. The company fosters local biotech growth via education/training programs and has played a key role in advancing Brazil’s translational science ecosystem. SAIL has also been involved with major philanthropic efforts—such as significant donations to the University of Oxford—to promote global health research collaborations between Brazil/Latin America and leading international institutions. It does not have its own drug pipeline or proprietary technology platforms but acts as an enabler/catalyst within the broader healthcare innovation landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sail for Health.